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Inorganic materials have properties that can be advantageous in
bioencapsulation for cell transplantation. Our aim was to engineer a
hybrid inorganic/soft tissue construct by inducing pancreatic islets to
grow an inorganic shell. We created pancreatic islets surrounded by
porous silica, which has potential application in the immunoprotection
of islets in transplantation therapies for type 1 diabetes. The new
method takes advantage of the islet capsule surface as a template for
silica formation. Mouse and human islets were exposed to medium
containing saturating silicic acid levels for 9–15 min. The resulting
tissue constructs were then cultured for up to 4 wk under normal
conditions. Scanning electron microscopy and energy dispersive X-
ray spectroscopy was used to monitor the morphology and elemental
composition of the material at the islet surface. A cytokine assay was
used to assess biocompatibility with macrophages. Islet survival and
function were assessed by confocal microscopy, glucose-stimulated
insulin release assays, oxygen flux at the islet surface, expression of
key genes by RT-PCR, and syngeneic transplant into diabetic mice.
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TO CREATE 3D TISSUE CONSTRUCTS for transplantation therapies,
cells are typically encapsulated within organic polymers, either
synthetic or natural, such as collagen or alginate. For applica-
tions requiring protection from the immune system, however,
inorganic or hybrid (inorganic/organic) materials may offer a
different set of useful functions and properties to be used as
alternatives to or in conjunction with the organic polymers.
Porous silica is an attractive material for these applications
because of its mesoporosity, potential to create hierarchical
structures, optical transparency, capacity for biofunctionaliza-
tion, performance in precision size exclusion, and bioactivity.
Our work focuses on primary pancreatic islets because of
their importance in therapies for type 1 diabetes. The Edmon-
ton protocol of islet transplantation in humans (40) has dem-
onstrated remarkable short-term success, with 80% of individ-
uals achieving insulin independence at 1 yr posttransplant;
however, this rate decreases to only about 10–15% at 5 yr (3).
Multiple mechanisms contribute to the progressive loss of graft
function but likely include an immediate blood-mediated re-
sponse (IBMR) (1, 37), poor revascularization and hypoxia (9,
16), and ongoing auto- and alloimmune responses (38). Pro-
tection of islets or stem cell-derived pseudo-islets by protective
membranes could significantly improve transplant outcomes
for patients.
The sol-gel synthesis method of forming solid porous silica
under biologically friendly temperatures and pH has been used
to encapsulate first biomolecules and later living cells since the
early 1990s. Early attempts to use silica as a microencapsula-
tion matrix for islets employed bulk sol-gel techniques, result-
ing in islets encased in thick silica slabs or spheres (34, 35).
These implants were able to supply enough insulin to prevent
urinary excretion of glucose in NOD mice for almost 11 wk
(35); however, bulk materials can create issues by creating
diffusion barriers, increasing hypoxia, increasing transplant
volume, and inserting delays in the glucose-insulin control
system. Carturan and colleagues achieved thin silica encapsu-
lation of islets by using the Biosil process (5, 33). This method
involves exposing cells to a gas stream comprised of N2 and
vaporized TEOS [Si(OCH2CH3)4] and DEMS [HSiCH3-
(OCH2CH3)2]. Moisture in the atmosphere and on the cell
surface allows for the reaction of the alkoxysilanes and depo-
sition of a sol-gel shell. When implanted, the direct sol-gel
silica tissue interface did not demonstrate signs of inflamma-
tory cell aggregation or an immune reaction, providing evi-
dence for the biocompatibility of the material used in tissue
encapsulation applications (5).
Here, we present a process by which the islet surface acts as
a nucleation site to template the formation of a thin, islet-
specific, porous silica shell around primary murine and human
islets in a liquid-medium environment. In essence, the islets
grow their own protective shell. This simple, wet chemical
process is conducted in growth medium under standard cell
culture conditions, is amenable to a variety of methods for
controlling physical, chemical, and biological material proper-
ties, and could easily be integrated into existing GMP islet
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handling protocols. In addition, the solution phase nature of our
method could be used in future work to mimic the chemistry
found naturally in organisms such as diatoms to form hierar-
chical materials with ordered nano- and microstructure to more
precisely control the mass transport, mechanical properties and
stability of the encapsulant. The purpose of this paper is to
evaluate the function of islets over time in culture after coating
with a silica layer.
MATERIALS AND METHODS
Murine islet harvest and culture. Islets used for in vitro studies
were harvested from 8- to 12-wk old CD-1 mice (Charles River,
Wilmington, MA) using the procedure described in Stull et al. (43).
Islet isolation studies were approved by the Indiana University Insti-
tutional Animal Care and Use Committees using AALAC guidelines.
After harvest, islets were incubated at 37°C in RPMI 1640 medium
supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and
100 g/ml streptomycin (Invitrogen, Carlsbad, CA) prior to encapsu-
lation and analysis.
Human islet culture. Human islets were obtained from human
cadaveric donors through the Integrated Islet Distribution Program
(IIDP). All human material was deidentified and therefore IRB ex-
empt based on criteria of and review by the Purdue Institutional
Review Board. Human islets were handled using protocols approved
by the Purdue Institutional Biosafety Committee. Upon arrival, islets
were incubated at 37°C in DMEM (GIBCO 11054) supplemented
with 10% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml
streptomycin (Invitrogen) for 24 h prior to encapsulation and analysis.
Enriched silica solution preparation. Tetramethyl orthosilicate
(TMOS, Sigma-Aldrich) was hydrolyzed in a 1:16 mol ratio (TMOS:
H2O) deionized water solution using 2.27 l of 0.04 molar hydro-
chloric acid initiator per 1 g of solution. The mixture was stirred
vigorously for 10 min until clear. The methanol produced by the
hydrolysis reaction was removed from the solution by rotary evapo-
ration under vacuum at 45°C (30% reduction in solution volume). The
resulting saturated silica solution was refrigerated and used within 8 h
of synthesis.
Islet encapsulation. Mouse islets suspended in culture medium
were placed in a 15-ml centrifuge tube and pelletized using centrifu-
gation. The medium was aspirated from the pellet. The islets were
then resuspended in a silica mineralizing solution composed of 10 ml
of -MEM with L-glutamine medium (Mediatech, VWR), 500 l of
phosphate-buffered saline (Invitrogen), and 300 l of enriched silica
solution. Immediately after resuspension, the islets were transferred to
a sterile 100-mm Petri dish and placed in an incubator for 15 min.
After incubation, the mineralizing solution was gently aspirated from
the islets and replaced with 10 ml of fresh warm (37°C) -MEM to
halt silica deposition. Encapsulated islets were returned to the incu-
bator for 4 h to stabilize the mineral layer. The -MEM medium was
then removed and replaced with 10 ml of fresh RPMI culture medium.
Samples of encapsulated islets were incubated for up to 28 days, with
fresh medium exchange 2–3 times/wk, prior to analysis.
Human islets were encapsulated using a similar procedure. To
determine the optimal encapsulation time, islets were exposed to
mineralizing solution for 9, 12, or 15 min. After exposure, the
mineralizing medium was removed and replaced with serum-free
-MEM for 4 h followed by medium exchange with DMEM-based
human islet medium. A subpopulation of encapsulated islets was
placed in murine RPMI culture medium to determine the effect of
medium type on secondary biomineralization.
Scanning electron microscopy. Encapsulated mouse islets incu-
bated for 0, 1, 2, 4, 7, and 14 days and human islets incubated for 0,
2, 7, and 14 days were immersed in a 4% glutaraldehyde-sterile
phosphate buffer solution for 1 h at room temperature. The samples
were then dehydrated using a series of ethanol solutions (25, 50, 75,
90, and 100%, respectively, 20-min exposure). Upon removal from
the final ethanol wash, the samples were gently pipetted onto a
scanning electron microscopy (SEM) sample post covered in carbon
tape. Residual ethanol was removed, and the islets were allowed to
dry for 12 h. Samples were then placed in a desiccating chamber prior
to SEM imaging using an FEI NOVA nanoSEM high-resolution
FESEM.
Energy-dispersive X-ray spectroscopy. Encapsulated islets were
fixed in 4% glutaraldehyde-sterile phosphate buffer solution for 1 h,
washed in deionized water to remove residual medium, dehydrated,
and mounted as previously described. The samples were then placed
in a desiccating chamber prior to analysis using an OXFORD INCA
250 energy-dispersive X-ray detector (EDS). Spectra were collected
from both surface scans and from point sources on the islet surfaces.
Surface element composition is reported as atomic percentage (at%).
Self-referencing biosensor quantification of oxygen flux. Time-
resolved metabolic flux was measured in single islets by oscillating an
oxygen biosensor perpendicular to the islet/coating surface. This
technique, known as self-referencing, converts concentration sensors
into dynamic biophysical flux sensors for quantifying real-time cel-
lular transport (26, 31, 36, 39). Analyte flux is calculated using Fick’s
first law of diffusion (25) by continuously recording differential
concentration (C) while oscillating the microsensor between two
locations separated by a fixed excursion distance (X). An optical
oxygen sensor was constructed by immobilizing an oxygen-quenched
fluorescent dye (platinum tetrakis pentafluoropheynl porphyrin) on the
tip of a tapered optical fiber (tip diameter 5 m) (29). Background flux
was recorded in bulk medium at least 5 mm away from cellular
material for 5 min. Flux at the islet/coating surface was measured in
murine islets before encapsulation and 4 h, 1 day, 2 days, 7 days, and
21 days after encapsulation (n  3). After 20 min of recording, a 1
mM bolus of potassium cyanide (KCN) was added to the medium to
disrupt oxidative phosphorylation and abrogate islet metabolism as
recording continued for another 20 min.
Cell viability imaging and quantification. Silica-coated mouse
islets were exposed to a combination of CellTracker Green CMFDA
(live cell), propidium iodide (PI; permeable membrane), and Hoechst
33342 (nucleic acid) stains (Invitrogen). Cells were first incubated in
culture medium containing 10 M CellTracker Green CMFDA stain
for 30 min. The medium was then replaced with warm (37°C)
serum-free medium supplemented with 1 l/ml PI (1 mg/ml) and 2
l/ml Hoechst 33342 (10 mg/ml) solutions. The cells were allowed to
incubate for an additional 10 min prior to analysis by confocal
microscopy. A Nikon C1 confocal microscope with three laser lines
for Hoechst 33342 (Ex/Em 405/525), CellTracker Green (Ex/Em
488/525) and PI (Ex/Em 561/595) was used to run confocal scans on
murine islets. Images were acquired using a 10 objective lens at
5-m intervals along the vertical axis. The EZ-CI software package
was used for image capture and processing. A Radiance 2100 MP
Rainbow (Zeiss, Oberkochen, Germany) confocal/multiphoton micro-
scope equipped with green HeNe, 4-line argon, and Mai Tai lasers
was used to image human islets. Quantitative live/dead assay of
human islets was also performed using a Cell Counting Kit-8 (CCK-8;
Dojindo Laboratories, Japan).
Insulin assay. Coated islets were tested for insulin secretion ac-
cording to the method reported by Chen et al. and Crim et al. (7, 8).
Islets (50 islets/sample) were incubated in modified Krebs-Ringer
buffer (KRB, 2.5 mM glucose) at 37°C for 1 h. The samples were then
washed with fresh KRB (2.5 mM glucose) and incubated for an
additional 1 h. After incubation, the samples were washed and
incubated in a final KRB solution containing 25 mM glucose. The
supernatant was collected from each glucose exposure condition.
Insulin concentration was then measured using a mouse insulin
standard enzyme immunoassay (EIA) ELISA kit (Mercondia, Upp-
sala, Sweden).
RT-PCR. Paired sets of 50 encapsulated (2–3 donor mice per pool,
4–10 pools per time point) and nonencapsulated control (2–3 donor
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mice per pool, 3–10 pools per time point) were harvested from each
pool at 0, 4, 2, 7, 14, 21, and 28 days. Islet samples were washed with
PBS and placed into 350 l of RLT buffer with 1% -mercaptoetha-
nol. Both coated and uncoated islets were then mechanically lysed and
the samples stored at 80°C prior to analysis. RNA was processed
using an RNeasy kit (Qiagen, Valencia, CA). After purification, a
20-l reaction volume of MMLV reverse transcriptase and random
hexamers (Invitrogen) was used to convert 5 l of total RNA into
cDNA. Quantitative real-time PCR was then used to determine the
expression of Tbp, Actb, Ins-1/2, Pdx1, Nos2, and pre-Ins2. Three
microliters of the cDNA reaction (5-fold diluted) was used as a
template for PCR. A 22-l reaction volume containing Jump Start
Taq-Polymerase (Sigma-Aldrich, St. Louis, MO) and gene-specific
primers was added to the cDNA (25 l total volume) according to the
method of Chakrabarti et al. (6). SYBR Green probes purchased from
Applied Biosystems (Carlsbad, CA) were used according to the
manufacturer’s instructions. All samples were run (Eppendorf Mas-
tercycler Realplex Thermal Cycler, Hauppauge, NY) in at least
triplicate (n  3–10 replicates) and normalized to the expression
levels of the Tbp housekeeping gene. Primers described previously
include Ins-1/2 (20), pre-Ins2 (20), and Nos2 (44). For amplification
of Pdx1 the 5=-CGGACATCTCCCCATACGAAG-3= (forward) and
5=-CCCCAGTCTCGGTTCCATTC-3= (reverse) primers were used.
Gene expression of Actb, Ins-1/2, Pdx1, Nos2, and pre-Ins2 was
evaluated by the 2CT method and presented as fold up/down of
transcripts of the respective genes relative to control (8).
Macrophage cytokine release assay. Encapsulated and nonencap-
sulated islets were cocultured with macrophages, and TNF- release
was measured. RAW 264.7 macrophages were obtained as a gift from
Prof. Janice Blum at Indiana University of Medicine and seeded at a
density of 50,000 cells/cm2 onto a 24-well plate in DMEM supple-
mented with 10% fetal bovine serum and 1% penicillin-streptomycin.
The cells were incubated in the plate for 24 h after seeding. After 24
h, the plate was rinsed with fresh medium to remove nonadherent
macrophages. Fresh DMEM containing lipopolysaccharide (LPS, 100
ng/ml) was then added to each well, and the cells were allowed to
activate for another 24 h. After 24 h, LPS was completely removed
from the plate by rinsing the wells several times with PBS. Fifty
encapsulated or nonencapsulated islets were added into each well with
1 ml of islet culture medium. After 1, 3, or 5 days of coculture
incubation, the medium from each well was collected and replaced
with a fresh medium. To determine TNF- content secreted by the
activated macrophages, the collected medium after each time point
was measured by an enzyme-linked immunosorbent assay (ELISA)
kit (R&D systems, Minneapolis, MN) following the manufacturer’s
instructions.
Transplantation of encapsulated islets into diabetic mice. Male
C57BL/6J mice (8–12 wk old) were purchased from Jackson Lab (Bar
Harbor, ME) and used as both recipient and donor mice. Recipient
mice were rendered diabetic by one (180 mg/kg) or two (125 mg/kg)
intraperitoneal injections of streptozocin (Sigma-Aldrich) 5 days prior
to transplantation. Blood glucose was monitored daily after the injec-
tion, and mice were determined hyperglycemic when their minimal
glucose level was 	18 mmol/l for 2 consecutive days before trans-
plantation. Prior to transplantation, anesthesia of recipient mice was
induced and maintained by isoflurane. Five hundred encapsulated or
nonencapsulated islets were pelletized by centrifugation and trans-
planted under the kidney capsule. After transplantation, glucose levels
of each recipient mouse were measured every other day with an
AlphaTrak blood glucose monitoring system (AlphaTrak; Abbott,
Chicago, IL).
RESULTS
A thin silica coating forms at the surface of mouse and
human islets. After exposure to the silica mineralizing medium
for 15 min, a thin, smooth silica membrane coating was
observed at the surface of mouse islets and human islets. EDS
confirmed the presence of silica by the emergence of a silicon
peak that was not present in control islets (Fig. 1).
To visualize the thickness of the layer, we intentionally
disrupted the coating with a harsh series of alcohol dehydration
and centrifugation, cracking the silica to partially expose the
islet surface (Fig. 2). This method illustrated a silica layer
thickness on the order of micrometers. A comparison of ele-
mental content in this cracked sample confirmed a 4.03 at% Si
over the shell and 0.72% residual Si at the underlying exposed
islet surface (Fig. 2).
Similarly, human islets also formed a thin silica shell after
exposure to saturated silica medium. SEM indicated that a
silica layer was deposited on the surface of human islets after
exposure to silica medium. EDS of samples exposed for 9 (n
21), 12 (n  17), or 15 (n  10) min produced Si surface
concentrations of 0.93 
 0.07, 1.03 
 0.12, and 0.75 
 0.06
at% (
SE) respectively.
Fig. 1. Energy-dispersive X-ray (EDS) spectra
of mouse and human islets show emergence of
significant silicon peak at islet surface 4 h after
exposure to silicification medium. Unexposed
mouse (A) and human (C) control islets show
no detectible level of silicon. Mouse (B) and
human (D) islets showed a silicon peak after
culture that in general ranged from 1 to 8% by
weight relative to other detectible elements
(typically C, O, N, S, P).
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Silica-coated islets form secondary calcium phosphate lay-
ers over time when cultured in RPMI but not DMEM medium.
To understand how the coating was affected by time in culture,
we monitored the elemental composition of the islet coating on
mouse islets, using SEM and EDS over a period of 14 days.
Over time in RPMI medium, the coated islet surface formed a
new layer comprised of calcium and phosphate (CaP) (Fig. 3).
A calcium and phosphate peak emerged in the EDS spectra by
4 days in culture. The at%s of these elements were around 4
and 3%, respectively, and began to level off at around 8 and
5% after 2 wk in culture (Fig. 4). This result is consistent with
a secondary biomineralization event in which silica present on
the cell surface nucleated the deposition of a calcium phos-
phate (CaP) layer from the medium.
At 4 days (Fig. 3A), the coating displayed a rounded granular
morphology indicative of amorphous CaP. Over time, the CaP
layer continued to mature, transitioning to a form that visually
appeared more crystalline (Fig. 3B). The ratio of calcium to
phosphorus (Ca/P) can be used to infer the degree of crystal-
linity of the deposit (15, 22). Point source EDS analysis of the
elemental composition of the CaP layer displayed a Ca/P ratio
of 1.37 at the 4 day time point (Fig. 4, inset). Materials having
a ratio 1.5 are usually considered to be amorphous. By day
seven the Ca/P ratio increased to 1.42. By the 14-day time
point, CaP apatite crystals (Ca/P  1.67) completely covered
the islet surface.
We hypothesized that the difference between mouse and
human islets was due to the differences in their standard
medium conditions. To test the effect of medium conditions,
we cultured human islets in mouse medium (RPMI) after
encapsulation and compared them to coated human islets
cultured in DMEM. Incubation of silica-coated human islets in
RPMI resulted in the formation of a secondary CaP layer in
encapsulated human islets (Fig. 5), similar to that observed for
mouse islets.
Biomineralized mouse and human islets cells survive encap-
sulation and culture. Fluorescence microscopy was used to
observe mouse and human islet stress and survival after en-
capsulation (Fig. 6). At 4 h after encapsulation, PI-positive-
stained cells were apparent relative to preencapsulation control
islets; however, the majority of the islets were positive for live
cells. By day 2, the number of PI-positive cells decreased
comparable to the control sample, indicating that either dead
cells or cellular debris had dissipated into the medium or that
membrane damage was repaired. Importantly, we did not
observe indications of a necrotic core.
Imaging of human islets revealed a small number of PI-
permeable cells distributed evenly throughout the islet (Fig. 7).
Fig. 2. Scanning electron micrograph (SEM)
image of a mouse islet with a silica coating
that was partially removed to reveal the
underlying islet (right portion of islet). EDS
spectrum 1 was taken from a region where
the coating remained in place (left) and had
a silicon peak corresponding to 4.0 atomic%
(8.6% by weight). EDS spectrum 2 was
taken from a region where the coating was
removed (right) and had a silicon peak of 0.7
atomic% (1.5% by weight).
Fig. 3. After several days in culture in RPMI,
mouse islets form a secondary calcium phos-
phate (CaP) layer. At 4 days posttreatment
(A), granules of CaP could be seen on the
surface of the islets. By 14 days (B), this
layer completely covered the islets surface.
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Quantification of islet cell viability in human islets by a
dehydrogenase activity-based assay kit showed a possible but
not statistically significant decrease in cell viability immedi-
ately after encapsulation (Fig. 7C). Interestingly, by day 2,
silica-coated human islets had a greater proportion of viable
cells relative to control islets. This improved viability persisted
at 7 days in culture.
Biomineralized mouse islets actively take up oxygen after
encapsulation. We used a self-referencing oxygen optrode to
measure oxygen flux at the surface of the mouse islet before
and at varying times after silica encapsulation (Fig. 8). At each
time point, we measured background flux (away from the cell),
flux at the surface, and after treatment with KCN. The islets
were treated with KCN to inhibit cellular respiration and
confirm the cellular nature of the measured flux. KCN signif-
icantly reduced the flux at the islet surface in all cases. Control
mouse islets on day 0 had an average oxygen flux of 55.8 

12.3 pmol·cm2·s1. Immediately after encapsulation, the
measured flux in mouse islets was reduced but remained
unchanged in in culture over time.
Mouse islets retain glucose-stimulated insulin release after
coating with silica. A comparison of glucose-stimulated insulin
release showed few differences between control and encapsu-
lated mouse islets over time (Fig. 9). Immediately after encap-
sulation, the encapsulated islets released more insulin at low
glucose relative to controls (Fig. 9A); however, by 2 days, the
basal release at low glucose was the same as control. At 28
days, silica-coated islets had significantly lower basal insulin
release. When stimulated with high glucose, encapsulated and
control islets showed similar release levels at all time points
except at 7 days. No statistical difference in relative insulin
release (ratio of release at high glucose to release at low
glucose) was observed between control and encapsulated
mouse islets at any time point after encapsulation (Fig. 9C).
Both control and encapsulated islets demonstrated a relatively
low stimulation index (2) at the 0- and 2-day time points
(corresponding to 1 and 3 days postharvest). By 7 days after
encapsulation (8 days postharvest), both encapsulated and
control islets displayed a stronger stimulation index (8),
Fig. 4. CaP formation begins after 2 days in culture for
silica-coated mouse islets. EDS analysis confirms initial
formation of a silica deposit followed by growth of a
CaP mineral layer upon incubation in RPMI. Concen-
tration of the elements Si, Ca, and P at the encapsulated
murine islet surface after 4 h (n  7), 1 day (n  4), 2
days (n  9), 4 days (n  9), 7 days (n  7), and 14
days (n 4) of incubation are shown vs. time in culture.
Point source scans at CaP nodules at 4 days (n  9), 7
days (4), and 14 days (n 8) show an increasing Ca/P
ratio (inset) (atomic% 
 SE).
Fig. 5. Human islets do not form CaP layers
when cultured in DMEM. SEM of human
islets after silica coating followed by 7 days
of culture in different media conditions. Hu-
man encapsulated islets incubated in DMEM
(A) do not form a secondary CaP layer,
whereas those incubated in RPMI (B) de-
velop CaP deposits. White arrow indicates
portion of exposed islet surrounded by the
CaP encapsulant.
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which was maintained for the duration of incubation up to 28
days.
Biomineral encapsulation does not significantly alter ex-
pression of -cell-associated genes in mouse islets. We mea-
sured transcript levels of -actin (Actb), and -cell-associated
transcripts, Pdx1, preinsulin (pre-Ins2), and insulin (Ins-1/2)
by using the housekeeping gene Tbp as a reference (Fig. 10).
Again, we found very few differences between control and
silica-coated mouse islets at all times after encapsulation.
Levels of pre-Ins2 and Pdx1 transcripts were reduced imme-
diately after encapsulation but recovered by day 2. No differ-
ences in Ins-1/2 transcript levels were observed at any time
point.
Pdx1 is a -cell-specific transcription factor associated with
the regulation of several -cell-specific genes (6). Ins-1/2, the
transcript responsible for insulin production, is commonly
associated with functional islets (2). Ins-1/2 is expressed at
high levels in insulin-producing cells and possesses a long
half-life (17). The pre-Ins2 transcript exists at lower levels and
has a faster turnover rate (17). Expression of pre-mRNA is
therefore a good reference for acute changes in gene transcrip-
tion, indicating that the cells are responsive to their environ-
ment (17). Taken together, these results indicate that alterations
in functional gene expression of islets due to encapsulation are
limited and temporary.
In addition to the -cell-associated markers, inducible nitric
oxide synthase (Nos2) transcript was measured as an indicator
of cell stress in mouse islets (Fig. 11). Expression of Nos2
increased immediately after biosilicification in some but not all
samples, resulting in a high variability at the 0 time point. By
4 days, Nos2 transcripts returned to levels that were indistin-
guishable from control levels for the remainder of the culture
period. The apparent differences in averages at 0 and 2 days
failed tests for significance and were driven primarily by one or
two samples with high Nos2 measurements. This result may
reflect variability in the handling of the islets during the
biomineralization process.
Silica-coated islets increase TNF- levels in macrophage
coculture. To investigate the response of macrophages to
silica-coated islets, we cocultured encapsulated and nonencap-
sulated islets with macrophages and measured TNF- protein
levels at days 1, 3, and 5 (Fig. 12). The amount of TNF- was
not significantly different between the groups of macrophages
cultured with nonencapsulated mouse islets and macrophages
Fig. 6. Confocal imaging reveals some dead or membrane-permeable cells in mouse islets 4 h after coating that disappear by day 2 in culture. Islets were stained
with CellTracker Green CMFDA (live cell, green), propidium iodide (PI; permeable membrane, red), and Hoechst 33342 (nucleic acid, blue) stains. Images are
overlaid Z stacks of 19–24 images. Scale bar, is 200 m for all 3 images.
Fig. 7. Human islets are viable after silica coating and show improved viability in culture over time. Islets were stained with CellTracker Green CMFDA (live
cell, green) and PI (red). Confocal imaging reveals even distribution of a few PI-permeable cells 1 day (A) and 7 days (B) after coating. C: islet viability of
encapsulated human islets is reduced on the day of encapsulation but improved 2 and 7 days after encapsulation. *P  0.01 vs. groups of nonencapsulated islets.
All data normalized to nonencapsulated human islet viability. Error bars, 
1 SE (n  3–4 replicates per condition).
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cultured alone. However, when cocultured with biosilica-en-
capsulated islets, macrophages released more TNF- than
when they were cocultured with nonencapsulated islets and
when they were cultured alone. This result was consistent for
all time points examined. As a positive control, macrophages
were stimulated with LPS under all conditions (alone, cocul-
tured with nonencapsulated mouse islets, and cocultured with
encapsulated islets). A similar trend was observed when mac-
rophages were already stimulated with LPS. That is, the
amount of TNF- secreted from macrophages with encapsu-
lated islets was highest among the three groups.
Encapsulated biosilica islets reverse hyperglycemia in dia-
betic mice after syngeneic transplantation. To investigate
whether the silica-encapsulated islets could survive and func-
tion in vivo, syngeneic transplantation was performed in
C57BL/6J mice made diabetic by STZ injection. Figure 13
shows blood glucose levels of the recipient diabetic mice
implanted with 500 encapsulated or control islets after trans-
plantation. Encapsulated islets could reinstate normal glucose
control in mice as well as or better than nonencapsulated islets.
DISCUSSION
Silica is a proven material for protein separation and exclu-
sion. Material scientists have developed methods to create
hierarchical silica structures with well-defined nano- and mi-
croscale pores to precisely control mass transport and mechan-
ical properties. By far the majority of these methods use
conditions such as high temperature treatment or solvent ex-
change that are completely incompatible with living cells. Our
long-term goal is to translate and adapt the materials chemistry
of mesoporous silica to the cell and islet surface so that we can
create precision separation materials as an islet encapsulant.
Biological organisms such as diatoms and sponges create such
silica materials under physiological conditions and serve as
inspiration.
This work is a first step in achieving our goal and the first
demonstration of using the islet surface itself as a template for
silica synthesis in aqueous conditions. We showed that we
could grow thin films on both mouse and human islets. Previ-
ously, we demonstrated similar results by exposing Pseudomo-
nas aeruginosa and Nitrosomonas europaea biofilms to a
saturated silica solution, forming a silica layer that reduced cell
detachment from bacterial biofilms under fluid flow (21). The
formation of a similar bioencapsulant by four different multi-
cellular structures suggests a common mechanism that may be
adaptable to many different tissue types. Extracellular mem-
branes and matrices are studded with proteins and polysaccha-
rides containing hydroxyl (-OH) groups. We hypothesize that
such hydroxyls, which can participate in hydrogen (4, 18) and
covalent (23, 24) bonding with silicic acid molecules, serve as
a site for silica polycondensation at the tissue surface.
Our goal in this paper was to evaluate islet survival and
function in culture after silica coating. Cell staining, oxygen
flux measurements, stimulated insulin release, gene expression,
viability assays, and in vivo transplants all showed that the
Fig. 8. Oxygen flux at the surface of mouse islets decreased after coating with
silica but was stable over time in culture. Flux was measured perpendicular to
the islet surface in nonencapsulated mouse islets on day 0 (control, n  3), 4
h (n  3) after encapsulation, and 1 day (n  3), 2 days (n  3), 7 days (n 
3), and 21 days (n 4) after encapsulation and culture. KCN was added during
recording to inhibit cellular respiration and confirm cellular source of the
measured flux. Open bars, before KCN treatment; filled bars, after KCN
treatment; error bars, SD. *Significant difference at P  0.05.
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Fig. 9. Glucose-stimulated insulin release from biomineralized (silica-
coated) mouse islets. Insulin release from encapsulated mouse islets (filled
bars) is comparable to that of control mouse islets (open bars) when
stimulated with low (A) and high (B) glucose at varying times after
encapsulation. T  0 corresponds to immediately after encapsulation.
C: relative insulin release is the ratio of insulin released at high glucose
relative to low glucose. Data are presented as average 
 SD. *Significant
differences between pairs, P  0.05.
E1236 SILICA-COATED MOUSE AND HUMAN ISLETS
AJP-Endocrinol Metab • doi:10.1152/ajpendo.00081.2013 • www.ajpendo.org
 by 10.220.32.246 on Decem
ber 22, 2016
http://ajpendo.physiology.org/
D
ow
nloaded from
 
silica coating is compatible with islet survival and function in
culture for several weeks.
Although we largely saw good survival and function, there
were indications in the 4-h data, such as PI-positive cells and
decreased Pdx1 expression, that the islets may experience
some stress during the coating process. In contrast, insulin
transcripts were not affected by encapsulation, and glucose-
stimulated insulin release was indistinguishable from controls.
This stress could be caused by physical manipulation, exposure
to the silica-forming medium, or the formation of the material
itself. Any stress on the cells during the 5- to 15-min exposure
to the silica medium sol could be due to the silica monomer,
reduced pH that occurs during polycondensation, residual
methanol if methanol was not completely removed prior to
forming the sol, or physical agitation during handing of the
cells.
Interestingly, expression of inducible nitric oxide synthase,
Nos2, a sensitive responder to islet stress (28), was not signif-
icantly different between encapsulated islets and controls,
although a few of the many encapsulated islet samples did have
high Nos2 levels. This finding could be due to variability in the
encapsulation process indicating that automation or optimiza-
tion of the silicification might reduce these effects.
In contrast, at later time points, encapsulated islets per-
formed as well as or better than control islets in culture. Basal
insulin release at low glucose levels was lower for encapsu-
lated mouse islets than for controls at 28 days, and Pdx1
expression was higher for encapsulated mouse islets at 14 days.
In addition, the data presented may actually underestimate this
result. Although not quantified, a high attrition rate was ob-
served in nonencapsulated control mouse islets over time.
After 14 days of incubation, we observed that 50% of the
initial pool of islets died in vitro, a phenomenon commonly
observed in long-term culture. Only surviving islets were
available for sample collection, potentially biasing the control
data set. Encapsulated islets did not experience as high rates of
attrition. We observed apparent islet numbers remained at
80–90% of initial concentrations over the course of 3–4 wk.
This observation was quantified for human islets where we
measured an 40% increase in numbers of viable cells for
coated islets at 2 and 7 days in culture. We hypothesize that
providing the islets with a biomineral coating creates a 3D
Fig. 10. Silica coating of mouse islets does not alter transcript levels of -cell-associated genes. Real-time PCR analysis indicates that encapsulated islets retain
gene expression levels, consistent with those of nonencapsulated controls. Quantification of gene regulation for (A) Actb (cytoskeletal element), (B) Pdx1
(-cell-specific gene regulator), (C) pre-Ins2 (insulin gene pre-mRNA), and (D) Ins1/2 (gene encoding insulin) was conducted. All data are presented as fold
up/downregulation of transcripts of respective genes relative to the Tbp housekeeping gene. *Significant (P  0.05) relative to nonencapsulated controls at the
respective time point. All sample pairs were analyzed by one-way ANOVA. Error bars, 
1 SE (n  3–10 replicates per condition).
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support matrix for the islets in culture, improving their long-
term survival. Future work will investigate this hypothesis
more directly.
Taking all of the results into account, we conclude that the
stress experienced by the islets is limited and temporary;
however, future work may be directed at completely eliminat-
ing this stress as we optimize the coating procedures.
Interestingly, we saw that the silica was bioactive under
certain media conditions. While biosilica mouse islets readily
experienced secondary biomineralization by CaP formation,
human islets did not form CaP when cultured in standard
human islet medium. Several factors could influence the me-
dium’s ability to form precipitates, including serum protein
levels, glucose concentration, pH, temperature, and the con-
centration of calcium and phosphate ions. DMEM contains 1.8
mM Ca2 and 0.906 mM PO4, whereas RPMI contains 0.848
mM Ca2 and 5.64 mM PO4. This difference in ion balance,
alone or coupled with other factors such as higher glucose
concentration, may have allowed RPMI medium to form silica-
induced CaP mineral deposits.
There are several potential consequences of calcification in
mouse media. First and foremost, we must determine whether
this secondary biomineralization occurs in vivo. Because the
CaP formation was highly dependent on the media conditions,
the in vivo bioactivity may also depend on transplant site. In
addition, we may need to alter the media conditions for mouse
islets to prevent CaP formation in culture prior to transplanta-
tion or transplant soon after coating with silica. Such altera-
tions may not be required for silica-coated human islets;
however, this result will need to be confirmed with human
Fig. 11. Silica coating does not alter expression of Nos2 transcript levels. Nos2
transcript expression in encapsulated mouse islets (filled bars) vs. nonencapsulated
islets (open bars) measured at varying time points after encapsulation. T  0
corresponds to immediately after encapsulation. Data are presented as fold in-
crease relative to the Tbp housekeeping gene. All sample pairs were analyzed by
one-way ANOVA. Error bars, 
1 SE (n  3–10 replicates per condition).
Fig. 12. Encapsulated islets stimulate TNF- release by
macrophages. Extracellular TNF- protein was mea-
sured when macrophages were cocultured with biosilica
islets (encapsulated), control islets (nonencapsulated),
and when cultured alone (macrophages) with or without
activation of LPS. *P  0.01 vs. groups of nonencap-
sulated islet-macrophages and macrophages only. Error
bars, 
1 SE (n  3 replicates per condition).
Fig. 13. Silica-coated islets reverse hyperglycemia after syngeneic transplant in
diabetic mice. Blood glucose of STZ-induced diabetic mice after beingtrans-
planted with 500 encapsulated islets (encapsulated), nonencapsulated islets
(nonencapsulated), or saline (Sham). Error bars, 
1 SE (n  3, 2, and 4
replicates in groups of encapsulated, nonencapsulated, and sham, respectively).
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media supplements as opposed to the FCS, which was used
here.
From a different point of view, the bioactivity of silica may
be an advantage for transplanted islets. Unlike traditional
encapsulant materials, which are generally designed to interact
as little as possible with the body, bioactive glasses integrate
with surrounding tissues and could reduce the formation of
granulation tissue and a fibrous capsule around the transplant.
This type of bioactivity has been used in hard-tissue recon-
struction. Silica-based bioactive glasses, such as type 45S5
(46.1 SiO2 - 24.4 Na2O - 26.9 CaO - 2.6 P2O5, mol%), are used
to fill bone defects and improve bone-tissue interfaces (46, 47).
Studies have demonstrated that conditioned medium, com-
posed of 45S5 dissolution products and CCD-18Co human
fibroblast cellular products generated from exposure to partic-
ulate 45S5, significantly increases human dermal microvascu-
lar endothelial cell proliferation relative to tissue culture-
plastic controls (10). In future work, we may be able to exploit
these properties in vivo to generate an islet encapsulant that
rapidly binds to surrounding tissues, improving diffusion to the
implant by integrating with the surrounding microvasculature
system. Because one of the primary failure modes of encapsu-
lated islets is insufficient nutrient transport (11), biomineral-
ization as a route to healthy tissue integration could potentially
extend transplant lifetime while still providing a porous pro-
tective layer. Combining our approach with transplant into
capillary-rich tissue may further improve survival by increas-
ing oxygen availability and reducing hypoxia.
Our in vitro assay of biocompatibility indicated that the
silica-coated islets can aggravate macrophages in culture to
cause increased TNF- levels. These levels were as high as or
higher than LPS-induced activation. Surprisingly, encapsulated
islets without LPS seemed to result in higher TNF- levels
than encapsulated islets plus LPS, a result for which we do not
yet have full understanding. Future work may also need to
examine TNF- secretion from the islets themselves. Regard-
less, in vitro assays of the biocompatibility of biomaterials are
not always good predictors of in vivo biocompatibility. In this
case, we saw sufficient survival of transplanted islets in the
time course of weeks, suggesting that in vivo inflammatory
response was not a significant issue.
In our existing data set, oxygen transport into the cells from
the medium appears to be reduced yet stable after encapsula-
tion. This result could be due to reduced diffusivity of oxy-
gen through the layer; however, the alternative conclusion is
that the magnitude of the flux is simply decreased by the
experimental artifact of an increased distance between the
optrode and the islet. Flux is calculated from the concentration
gradient, which theoretically and experimentally decreases
with distance from the source or sink (30, 32), in this case the
islet surface. The coating imposes at least one to a few
micrometers distance between the islet and the surface of the
coating and therefore the islet surface and the optrode. In future
work, we will examine the transport properties of the material
more directly as we optimize the pore structure for protection
from the immune system. Regardless, we do not see evidence
of a necrotic core in our observations by confocal microscopy,
and the islets survive for weeks in vivo as indicated by
restoration of normal blood glucose levels in diabetic mice.
While the work here demonstrates the compatibility of
mouse and human islets with a biomineral shell, future work
must test the protective capabilities of that shell. Layer porosity
and diffusional properties of silica-based sol-gels can be al-
tered by manipulation of a number of factors during the
encapsulation process. Ongoing research is underway to im-
prove the chemical and physical durability of the sol-gel layer,
to optimize of the encapsulant system to maintain normal
levels of nutrient diffusion and insulin transport while provid-
ing cytokine barrier function, and to continue to measure the in
vivo behavior of silica-encapsulated islets. Proper design of a
silica encapsulant could allow for good transport of insulin
while protecting from even the smaller molecules of the im-
mune attack such as cytokines. Importantly, many years of
microencapsulation of islets with hydrogels, e.g., alginate, and
more recently organic coatings such as PEG, have shown
varying degrees of success and advantage (12–14, 19, 27, 41,
42, 45). One possible strategy is to incorporate the best mate-
rial properties from the organic systems with the inorganic
such as silica to create multifunctional hybrid composites.
Given the complex and difficult nature of immunoprotection,
such a multipronged strategy may have strength.
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